Kiran Mazumdar-Shaw of Biocon said in an exclusive interview at the Reuters India Investment Summit 2011 that the company is in advanced discussions with potential...
Kiran Mazumdar Shaw, Chairman of Biocon speaks about the Espirto Santo report that questions the company's accounting standards, Axi Corp, insulin business, Pfizer deal, Statin...
Biocon and Pfizer announced the conclusion of their alliance to commercialize Biocon's biosimilar versions of Insulin and Insulin analog products. The companies have agreed that...
Biocon and Pfizer announced the conclusion of their alliance to commercialize Biocon's biosimilar versions of Insulin and Insulin analog products. The companies have agreed that...